NCT05476302 (TELEPARK) is a clinical trial of Cognitive digital treatment in Parkinson Disease, sponsored by Istituto Nazionale di Ricovero e Cura per Anziani.

Who is sponsoring NCT05476302?

NCT05476302 is sponsored by Istituto Nazionale di Ricovero e Cura per Anziani.

What drugs are being tested in NCT05476302?

Interventions in NCT05476302: Cognitive digital treatment.

What condition does NCT05476302 study?

NCT05476302 studies Parkinson Disease, COVID-19, Mild Cognitive Impairment.

Is NCT05476302 still recruiting?

NCT05476302 is currently completed. Last updated 27 July 2022.

Last reviewed 2022-07-27 · How we verify

NCT05476302: TELEPARK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Remote Cognitive Intervention in Patients With Parkinson's Disease During the COVID-19 Pandemic

Completed Last updated 27 July 2022

What this trial tests

trial testing Cognitive digital treatment in Parkinson Disease in 18 participants. Completed in 31 October 2020.

Timeline

1 January 2020

Primary endpoint
31 October 2020

31 October 2020

Quick facts

Lead sponsor	Istituto Nazionale di Ricovero e Cura per Anziani
Status	Completed
Study type	OBSERVATIONAL
Enrollment	18
Start date	1 January 2020
Primary completion	31 October 2020
Estimated completion	31 October 2020
Sites	1 location across Italy

Drugs / interventions tested

Cognitive digital treatment

Conditions studied

Parkinson Disease — all drugs for Parkinson Disease →
COVID-19 — all drugs for COVID-19 →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Istituto Nazionale di Ricovero e Cura per Anziani — full company profile →

Who can join

Eligibility, any sex, with Parkinson Disease or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective study to evaluate the effect of a remote cognitive-rehabilitative intervention during the Covid outbreak in subjects with Parkinson's disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive Digital Intervention for Older Patients with Parkinson's Disease during COVID-19: A Mixed-Method Pilot Study.
Santini S, Rampioni M, Stara V, Di Rosa M, et al · · 2022 · cited 9× · PMID 36429562 · DOI 10.3390/ijerph192214844

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting

Other Istituto Nazionale di Ricovero e Cura per Anziani trials

Trials by the same sponsor.

NCT06984393 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Parkinson's Disease (DHEAL-COM-PD) · NA · not yet recruiting
NCT06984380 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP) · NA · not yet recruiting
NCT07435467 — Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline an · recruiting
NCT06984367 — A Socio-Technological Intervention in Community-Based Healthcare for Individuals With Mild Cognitive Impairment (DHEAL-C · NA · recruiting
NCT07002411 — Hospitality Oriented Service Perception Evolution With Robots (HOSPER) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05476302 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituto Nazionale di Ricovero e Cura per Anziani
Last refreshed: 27 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05476302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing